Valion Bio, Inc. (VBIO) Net margin 2021–2024
Valion Bio, Inc. (VBIO) net profit margin by fiscal year — reported net income divided by reported revenue.
-725.0%FY2024 · since FY2021: -675.7% → -725.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -725.0% | -24.0 pp |
| FY2023 | -701.0% | -152.3 pp |
| FY2022 | -548.7% | +127.0 pp |
| FY2021 | -675.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More VBIO financial trends
VBIO RevenueVBIO Net incomeVBIO Gross profitVBIO Gross marginVBIO Operating incomeVBIO Operating marginVBIO Operating cash flowVBIO Free cash flowVBIO Capital expendituresVBIO Return on equityVBIO Stock buybacksVBIO Dividends paidVBIO Total assetsVBIO Total liabilitiesVBIO Shareholders’ equityVBIO overview →